Toll-like receptor 4 ablation improves stem cell survival after hypoxic injury

Journal of Surgical Research

Volumn 177, Issue 2, 2012, Pages 330-333

  Brewster, Benjamin D ^a   Rouch, Joshua D ^a   Wang, Meijing ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b METHODIST HOSPITAL   (United States)

Author keywords

Hypoxia; Mesenchymal stem cells; TLR4; Toll like receptor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART PROTECTION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT; TOLL-LIKE RECEPTOR 4;

EID: 84866024490     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.04.042     Document Type: Article

References (14)

1. R.Z. Shi, and Q.P. Li Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease Biochem Biophys Res Commun 376 2008 247
2. F. Arslan, D.P. de Kleijn, and L. Timmers Bridging innate immunity and myocardial ischemia/reperfusion injury: The search for therapeutic targets Curr Pharm Des 14 2008 1205
3. J. Lei, Z. Wang, and D. Hui Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity Cell Immunol 271 2011 147
4. F. Liotta, R. Angeli, and L. Cosmi Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling Stem Cells 26 2008 279
5. S.B. Mkaddem, M. Bens, and A. Vandewalle Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia Oncotarget 1 2010 741
6. Y. Wang, A.M. Abarbanell, and J.L. Herrmann TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection PLoS One 5 2010 e14206
7. Z.J. Wang, F.M. Zhang, and L.S. Wang Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt Cell Biol Int 33 2009 665
8. D.J. Hausenloy, A. Tsang, and D.M. Yellon The reperfusion injury salvage kinase pathway: A common target for both ischemic preconditioning and postconditioning Trends Cardiovasc Med 15 2005 69
9. U. Maitra, N. Singh, and L. Gan IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes J Biol Chem 284 2009 35403
10. N. Singh, and L. Li Reduced oxidative tissue damage during endotoxemia in IRAK-1 deficient mice Mol Immunol 50 2012 244
11. B.D. Manning Balancing Akt with S6K: Implications for both metabolic diseases and tumorigenesis J Cell Biol 167 2004 399
12. I. Hers, E.E. Vincent, and J.M. Tavare Akt signalling in health and disease Cell Signal 23 2011 1515
13. W.H. Biggs 3rd, J. Meisenhelder, and T. Hunter Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1 Proc Natl Acad Sci U S A 96 1999 7421
14. B.M. Burgering, and R.H. Medema Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty J Leukoc Biol 73 2003 689